Fig. 1From: The efficacy and safety of angiogenesis inhibitors for recurrent ovarian cancer: a meta‑analysisThe PRISMA Flow Diagram of Study Selection. The PRISMA diagram included searches of databases, registers, and other sources and the various reasons for the excluded articlesBack to article page